Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) closed at $20.94 in the last session, down -4.12% from day before closing price of $21.84. In other words, the price has decreased by -$4.12 from its previous closing price. On the day, 0.51 million shares were traded. EYPT stock price reached its highest trading level at $22.02 during the session, while it also had its lowest trading level at $20.85.
Ratios:
We take a closer look at EYPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.45. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on January 22, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.
On November 02, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $20.
On April 21, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $33.Robert W. Baird initiated its Outperform rating on April 21, 2023, with a $33 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 02 ’24 when Jones David Scott sold 209 shares for $28.49 per share. The transaction valued at 5,954 led to the insider holds 37,962 shares of the business.
Paggiarino Dario A. sold 49,325 shares of EYPT for $1,265,539 on Jan 26 ’24. The Chief Medical Officer now owns 36,505 shares after completing the transaction at $25.66 per share. On Jan 26 ’24, another insider, Jones David Scott, who serves as the SVP & Chief Commercial Officer of the company, sold 26,017 shares for $25.38 each. As a result, the insider received 660,370 and left with 37,962 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 1043456960 and an Enterprise Value of 717875776. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.67 while its Price-to-Book (P/B) ratio in mrq is 3.86. Its current Enterprise Value per Revenue stands at 15.6 whereas that against EBITDA is -9.78.
Stock Price History:
The Beta on a monthly basis for EYPT is 1.66, which has changed by 2.6866198 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, EYPT has reached a high of $30.99, while it has fallen to a 52-week low of $4.22. The 50-Day Moving Average of the stock is -14.39%, while the 200-Day Moving Average is calculated to be 32.20%.
Shares Statistics:
According to the various share statistics, EYPT traded on average about 930.67K shares per day over the past 3-months and 535920 shares per day over the past 10 days. A total of 49.04M shares are outstanding, with a floating share count of 46.63M. Insiders hold about 6.42% of the company’s shares, while institutions hold 96.21% stake in the company. Shares short for EYPT as of 1711584000 were 6845404 with a Short Ratio of 7.36, compared to 1709164800 on 5724135. Therefore, it implies a Short% of Shares Outstanding of 6845404 and a Short% of Float of 18.73.
